[1]

[2]

ZHAO Wenchao, QIU Yanfang, TAN Rong. Targeting DNA damage response in tumor therapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 943-952.

[3]

TANG Mufei, SHEN Yunzhu, ZHANG Baoguo. Influence of CYP2D6 gene polymorphism on the effect of tropisetron in preventing chemotherapy induced nausea and vomiting [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 817-822.

[4]

LIN Zhong, XIE Qunli, LI Shengying, JIN Hui, XU Fenfen, XIE Liyun, JIANG Zhengli. Advanced of HER-2/neu epitope anti-tumor vaccine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1046-1052.

[5]

LV Wenlong, CHEN Xiuying, HONG Jinsheng, LIU Feng, ZHANG Weijian. Predictive value of Esophageal tumor volume based on CT measurement for concurrent chemo-radiotherapy with PF program（5-Fu+DDP） [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1373-1379.

[6]

LI Xiu, JI Zhaoning. Chemotherapy compliance of patients with digestive system cancer and its influencing factors [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 565-569.

[7]

SUN De-cong, CHEN Li, WU Zhi-yong, DAI Guang-hai. Diagnosis and management of the hepatitis B reactivation in patients receiving cytotoxic chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(5): 584-590.

[8]

ZHANG Ye, RUI Jing. Research progress of snake venom disintegrin in treatment of tumor [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(9): 984-988.

[9]

FAN Lan, XIE Hai-tang, ZHOU Hong-hao. Herb-drug interactions in oncology and potential mechanisms [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(2): 134-139.

[10]

WANG Dong-yan, LI Xin, ZHANG Hong-quan. Immune protecting on tumor-bearing mouse of C21 sterols in Baishouwu [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(2): 168-172.

[11]

SU Ying-jie, LI Jing, YAO Ming-hui, GONG Qin-yan. Radioprotective effect of rhTPO on mice and MO7e cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(1): 66-71.

[12]

[13]

TIAN Chun-tao, JIAO Shun-chang, WEI Xiu-fang. Experiment of advancing chemosensitization of Etoposide by insulin in vitro [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(9): 987-990.

[14]

SHAN Chang-min, LI Juan, LI Pu. Apoptosis and therapeutic for cells of liver cancers SHAN Chang-min, LI Juan, LI Pu [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 851-856.

[15]

HE Yang, JI Zhao-ning, WANG Lu. Expression of IGFBP-2 and its correlation with estrogen receptor, progesterone receptor in breast cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 898-901.

PDF (PC)

Knowledge